Technical information
Manufacturer
Laboratoires PROSTRAKAN PHARMA
Presentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
eNq1mE1z2jAQhu/8Co8PvWGbDwentcm0NGmZSaaUhGmnF0bYSxAVkivJQPrrK2MyIR15kgh0A8u8u9599WhxfLFdEWcNXGBGE7flBa4DNGUZpveJO7m7akbuRb8RL9EaHdzW8wKv1XadlCAhErdc9WaAqPB+3lx/BvV74G6/4cRstoRUPruvkJh4X5FY3KC8vMeJ1wxnzgrkgmWJmxdyd9WJheQqi/6G8d8iRynE/v7K4epy2j28Hvul2CtUCwH8GtF7rShQI8204ByoHCAJ94w/aKXn6bQd9c6CIDIKgcUYBCt4CiMkFyPO1jiDTB8JEQFGQeab7Bb4moAsg2jF/WW6EkbiaIm2Y/gz1Cf9Ua0O5FY2g2arF3bDs3Y7CLutnlEoflAqvXnUQ/h5zrNp+zwKO1HPB+pnnBHIJaJN9SkHjjNGDHs1YlwiYqlLWAye+81SHA5/XnRDhkVO0IO3FLlpqRBHahm4ooK9Bymf4I4rThFVs//0aUGI/8asJ3uKWMq4hNSAFVTWwORqbFqIAaMStvUdNeOf3O69iEGcTvYvo3r2j4oZwakp4hSEChByMh7WE84mHD4hARNujw4/MM3YRpyeOoddtpR9vgOnVlQ1pFV25KwVhsab6peyVM0JdFmUjfUVj7A4BjNDOmfHAka5VC/16FFr9tyNRyxFBGoGpKYhe5QvH+c5a863t6uqBa3ol8s7U7t8L4A/3O6+aqVxlhw22ozNNoCv/PlS7tVOTvJpJwij8073HVrlHx6H78Rw0K5EXzFnd6NO28z/XE+fhZS5eO/7m83GWyDRFEiV1Zvz158WF9qKnKIqCs1PTbb318DK6FCNUhWWLaU+q87bt7XVdEu/NFwcOzDvf78fzLUxJC/giF5U9LfG6OHl6bH/NC1bS3v0jDz2wuwmWyQxo7YmrGKm5/WxB41qLb3iihHf5nNc89Km1pqxX70w6jdiv3xZ1G/8AwyZIMY=
d9NvTVjyy9aZYkAL